Latisse® is the first and only prescription treatment approved by the FDA and Health Canada for lengthening and thickening your own eyelashes. It is a once-a-day treatment, applied topically to the base of your upper eyelashes. Patients in clinical trials saw results in as few as 8 weeks, with full results after 12 to 16 weeks. Latisse® was developed through years of research by Allergan®, a pharmaceutical leader with 60 years of expertise in prescription eye care products.

What It Treats:

Latisse® is a prescription treatment for hypotrichosis (inadequate or not enough lashes) to grow eyelashes longer, fuller, and darker.

Important Safety Information:

• If you use or have used prescription products for eye pressure problems, use Latisse® under the care of a healthcare professional.
• Latisse® may cause increased brown pigmentation of the colored part of the eye, which is likely permanent.
• Eyelid skin darkening may occur and may be reversible.
• Only apply at the base of the upper lashes. DO NOT APPLY to lower lid.
• Hair may grow on skin that Latisse® frequently touches.
• If you have eye problems or have had eye surgery, consult your healthcare professional about the use of Latisse®.
• Common side effects are itchy and red eyes.
• If discontinued, lashes gradually return to their previous appearance.

Results:

LATISSE® is the first prescription product to treat inadequate lashes—it’s believed to prolong the active eyelash growth phase. It’s clinically proven to deliver lashes that are fuller, longer, and darker at 16 weeks.

At 16 weeks in the clinical study, lashes were:

• 106% Fuller (136 LATISSE® patients) vs. 12% for the placebo group (140 patients)
• 25% Longer (137 LATISSE® patients) vs. 2% for the placebo group (141 patients)
• 18% Darker (135 LATISSE® patients) vs. 3% for the placebo group (138 patients)